Adipose tissue, once misunderstood as an inert energy storage depot, has now become a frontier in metabolic research. It serves not only as the body’s “energy bank” but also as an active endocrine and immune “command center”. Once dysfunctional, it is closely linked to the development of metabolic diseases such as type 2 diabetes and […]
Category: Diabetes news
Pre-existing Diabetes in Pregnancy: In-depth Interpretation of the Joint ES/ESE Clinical Practice Guideline
Health management not only during pregnancy but also before and after pregnancy is critical for maternal and neonatal outcomes. For women with pre‑existing diabetes mellitus (PDM), how to implement individualized full‑cycle treatment and management has long been a key clinical focus.At the 2025 Annual Meeting of the European Association for the Study of Diabetes (EASD), […]
Basic Research on Diabetic Retinopathy Establishes Core Evidence for Precision Diagnosis and Treatment
Basic research on diabetic retinopathy (DR) in 2025 focused on the dissection of pathological networks, biomarker discovery, and therapeutic target development, achieving multi‑dimensional breakthroughs covering immunity, metabolism, and the gut‑eye axis, and laying core evidence for precision diagnosis and treatment.In terms of pathogenic mechanism networks:Studies revealed that high glucose drives angiogenesis via the perlecan‑HIF‑1α axis […]
History of GDM Hides Long-Term Risks: Affects Cardiovascular Health in Women for Up to 40 Years Postpartum!
In January 2026, researchers from the First Affiliated Hospital of Anhui Medical University and the School of Public Health, Anhui Medical University, published a study entitled “Gestational Diabetes History and Cardiovascular Health Assessed by Life’s Essential 8 across Postpartum Intervals” in the Journal of the American Heart Association, an international journal in the cardiovascular field. […]
Professor Ye Jianping: Type 2 Diabetes Roots in Excess Energy
At a public conference, Professor Ye Jianping from the Metabolic Disease Research Center of Zhengzhou University shared a series of studies and conclusions on the mechanistic exploration of type 2 diabetes mellitus (T2DM). He delivered an insightful explanation of the biological mechanisms underlying T2DM pathogenesis and summarized its clinical therapeutic strategies and the mechanisms of […]
2026 ADA Standards of Care in Diabetes Officially Released! Quick Overview of Updates
The field of diabetes care is advancing rapidly, with new research, technologies, and treatments continuously emerging to improve the health and well-being of people with diabetes. Since 1989, the American Diabetes Association (ADA) guidelines have been updated annually, long leading global practice and reflecting the latest progress in the field. The 2026 ADA Standards of […]
Evidence-Based Support and Standard Construction Promote the Standardized Application of CGM
The 2025 ADA guidelines recommend the use of real‑time continuous glucose monitoring without fingerstick calibration (rtCGM) or intermittent scanned CGM (isCGM) for diabetes management in adolescent and adult patients receiving any type of insulin therapy.A systematic review and meta‑analysis of randomized controlled trials has shown that fingerstick‑calibration‑free continuous glucose monitoring (CGM) significantly improves glycemic control […]
Technological Innovation Drives Diabetes Management into a New Stage
In recent years, the concept of diabetes management has gradually shifted from intensive glycemic control to integrated glucose‑weight management, emphasizing equal importance of weight control and blood glucose regulation.The 2022 ADA/EASD consensus elevated weight management to a level equivalent to blood glucose control and cardio‑renal protection.The 2025 ADA guidelines and 2024 CDS guidelines also explicitly […]
Professor Andreas Liebl, Diabetes and Metabolism Center Bad Heilbrunn, Germany:New Advances Are Improving Patient Management
In recent years, numerous studies have emerged on the management of type 2 diabetes mellitus (T2DM) and obesity.According to Professor Andreas Liebl, the most noteworthy advances currently come from the development of a new generation of incretin-based drugs, including GLP‑1 receptor agonists, GIP receptor agonists, and in the future, possibly even triple agonists that also […]
Global Diabetes in Adolescents and Young People Has Risen Significantly in Recent Years
Traditionally, diabetes in adolescents was mostly considered type 1 diabetes. However, with improved living standards, earlier puberty, and other factors, the global prevalence of diabetes among young people has increased markedly in recent years. The main forms are early-onset type 2 diabetes and type 1 diabetes, which differ in pathogenesis, epidemiological characteristics, and health impacts.Type […]